HTFL (HeartFlow) Net Current Asset Value: $1.78 (As of Mar. 2026) — 87% Below Median


HTFL HeartFlow Inc HTFL
12 GF Score
Price $29.33
! 4 Warning Signs
View Full Analysis

What is HeartFlow Net Current Asset Value?

HeartFlow HTFL -15.83% 12 Net Current Asset Value is $1.78 as of Mar. 2026, which is 87% below its 10-year median of 13.67. GuruFocus rates HTFL with a GF Score™ of 12/100. The stock has 4 warning signs investors should review. Among 274 Healthcare Providers & Services companies, HeartFlow ranks worse than 83.21% on this metric.

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

HeartFlow's net current asset value per share for the quarter that ended in Mar. 2026 was $1.78.

The historical rank and industry rank for HeartFlow's Net Current Asset Value or its related term are showing as below:

HTFL' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 12.9   Med: 13.67   Max: 19.59
Current: 16.48

During the past 3 years, the highest Price-to-Net-Current-Asset-Value Ratio of HeartFlow was 19.59. The lowest was 12.90. And the median was 13.67.

HTFL's Price-to-Net-Current-Asset-Value is ranked worse than
83.21% of 274 companies
in the Healthcare Providers & Services industry
Industry Median: 5.995 vs HTFL: 16.48

HeartFlow  (NAS:HTFL) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


HeartFlow Net Current Asset Value Related Terms


HeartFlow Net Current Asset Value Historical Data

* Premium members only.

The historical data trend for HeartFlow's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeartFlow Net Current Asset Value Chart

HeartFlow Annual Data
Trend Dec23 Dec24 Dec25
Net Current Asset Value
-10.10 -11.11 1.89

HeartFlow Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.52 -11.61 2.61 1.89 1.78

HTFL vs PRVA, WAY, DOCS: Net Current Asset Value Comparison

For the Health Information Services subindustry, HeartFlow's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HeartFlow Price-to-Net-Current-Asset-Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HeartFlow's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where HeartFlow's Price-to-Net-Current-Asset-Value falls into.


HTFL
12GF Score
HeartFlow Inc HTFL
Net Current Asset Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HeartFlow Net Current Asset Value Calculation

HeartFlow's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2025 is calculated as

Net Current Asset Value Per Share(A: Dec. 2025 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(220.204-58.805-0-0)/85.281
=1.89

HeartFlow's Net Current Asset Value (NCAV) per share for the quarter that ended in Mar. 2026 is calculated as

Net Current Asset Value Per Share(Q: Mar. 2026 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(211.83-58.307-0-0)/86.105
=1.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Current Asset Value of $1.78 mean?
HeartFlow (HTFL) has a Net Current Asset Value of $1.78 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on HeartFlow and its competitors. This is 87% below median its historical median of 13.67. Over the past decade, HeartFlow's Net Current Asset Value has ranged from 12.90 to 19.59. According to the industry distribution chart, HeartFlow ranks #228 out of 274 companies in the Healthcare Providers & Services industry, placing it in the top 83.2%.
Is HeartFlow's Net Current Asset Value too high?
HeartFlow's current Net Current Asset Value of $1.78 is 87% below median its 10-year median of 13.67. Over the past 10 years, this metric has ranged from a low of 12.90 to a high of 19.59. The Healthcare Providers & Services industry median Net Current Asset Value is 6.00. HeartFlow's value of $1.78 is 70.3% below this industry median. Based on the distribution chart, HeartFlow ranks #228 out of 274 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, HeartFlow has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does HeartFlow's Net Current Asset Value compare to PRVA and WAY?
According to the Healthcare Providers & Services industry distribution chart, HeartFlow ranks #228 out of 274 companies for Net Current Asset Value. This places HeartFlow in the lower half of its industry. The industry median Net Current Asset Value is 6.00. HeartFlow's value of $1.78 is 70.3% below this benchmark. Historically, HeartFlow's own Net Current Asset Value has ranged from 12.90 to 19.59 over the past decade. While the company's 10-year median is 13.67 vs. the industry median of 6.00, HeartFlow has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Healthcare Providers & Services company?
The median Net Current Asset Value among Healthcare Providers & Services companies is 6.00, based on 274 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HeartFlow's current Net Current Asset Value of $1.78 is 70.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on HeartFlow and its competitors. For the Healthcare Providers & Services industry, the median Net Current Asset Value is 6.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HeartFlow's current Net Current Asset Value is $1.78, which is 87% below median its own 10-year median of 13.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartFlow stock overvalued right now?
HeartFlow (HTFL) has a current Net Current Asset Value of $1.78. The current Net Current Asset Value is $1.78, which is 87% below median its 10-year median of 13.67 and 70.3% below the Healthcare Providers & Services industry median of 6.00. HeartFlow's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For HeartFlow (HTFL), the current Net Current Asset Value is $1.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HeartFlow Business Description

Address 331 East Evelyn Avenue, Mountain View, CA, USA, 94041
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
12GF Score

Get the complete analysis for HTFL

Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$29.33
Price